It is finally done, Dow Chemical (DOW) and Rohm & Haas (ROH) are one. Some details:
From the SEC Filing:
As part of today’s agreement, Rohm and Haas’s two largest shareholders have agreed to purchase $2.5 billion in face value of perpetual preferred equity issued by Dow. In addition, one of the shareholders, the Haas Family Trusts has agreed that at Dow’s option, they will make an investment in an additional $500 million of Dow’s equity. These equity investments substantially reduce the debt financing required to fund the acquisition, Dow has restructured the transaction to essentially pay the equivalent of $63 per share in cash, and $15 per share in face value of preferred equity securities. To fund the acquisition of Rohm and Haas, Dow will use the proceeds from the equity issuances to reduce the amount it would otherwise be required to draw down from the $12.5 billion bridge loan, which was renegotiated last week to provide a one-year extension on $8 billion of the total loan. The financing for the acquisition also includes equity investments of $3 billion by Berkshire Hathaway and $1 billion by the Kuwait Investment Authority (KIA) in the form of convertible preferred equity.
Acquisition Delivers Significant Cost and Revenue Synergy Opportunities
Dow plans to achieve its long-term goals for the Rohm and Haas acquisition with a carefully conceived path forward built upon the cornerstones of financial discipline and operational excellence. Dow has put into place an even more aggressive plan to realize combined synergies of $1.3 billion, up from $910 million, as originally outlined. With a long history of operational excellence, Dow has a demonstrated willingness to make the decisions necessary to maintain and improve financial performance. Cost savings will come from increased purchasing power for raw materials for the combined company; manufacturing and supply chain work process improvements; office consolidations and the elimination of redundant corporate overhead for shared services and governance.
Finally, as part of the Company’s plans to improve its financial position, Dow has commenced an aggressive asset divestment program involving a number of Dow and Rohm and Haas business units expected to yield approximately $4 billion including:
1. Dow’s 45 percent stake in Total Raffinaderij Nederland NV (TRN), the Dutch petroleum refining partnership with Total Group. The sale process is underway;
2. Some of Dow’s equity stakes in its olefins and derivatives business in SE Asia. Preliminary discussions with the relevant parties have already begun;
3. Morton Salt, a division of Rohm and Haas, contingent upon the closing of the proposed acquisition of Rohm and Haas by Dow. Interested parties have submitted bids, and Dow will evaluate these bids as appropriate over the course of the coming weeks to determine timing of the sale process.
Divestments from this program, in addition to the increased equity financing will essentially address the cash shortfall created by the failure of the K-Dow transaction to close as scheduled.
Here is the presentation done immediately after:
Dow Chemical / Rohm & Haas Combines Entity
For those who do not want to go through the whole presentation, here is the slide that answers most people questions, the financing and the bridge loan:
So, where are we?
Dow is offically no longer a commodity chemical company after April 1. 70% of 2008 EBITDA will be from specialty products. This will cause immediate PE expansion from high single digits that commodity producers tend to have the mid to high teens the specialty ones enjoy to to their more consistent earnings. Dow will be cash flow positive in 2009 and have the term loan used to settle the transaction paid off withing the year.
Interestingly enough, only $4.3 billion of the loan reduction will come from asset sales. Remember Dow was looking at $9.5 billion from the Kuwait JV that Kuwait bailed on essentially at the signing. Let’s also not forget that Dow is entering arbitration with Kuwait over damages in the case. Dow has said in the past they are owed the $2.5 billion breakup fee in the deal. There is also a scenario is which Kuwait decides to renter talks with Dow for some of the businesses they were originally suppose to buy. Neither of these scenario’s are baked into current projections yet are very real possibilities.
But lets look around. Negativity is everywhere. Few would question the operational ability of the combined entity and the global powerhouse it now is. But, management at Dow does have a real credibility problem. For the price paid for this deal, to the failed Kuwait JV and the dividend cut, investors are left wondering “what’s next?”.
That is going to be a bit of a cloud over the company until they can report some positive news. We need some unexpected good news, not bad. Yes, I know that Rohm & Haas is a one of a kind company and that Dow’s was not even the highest offer in the auction for it. Yes, I know Dow had no control over the Kuwait decision. Yes, I know that the dividend cut had to happen and were it not for the Kuwait decision, would not have happened. I know all this and all of it is true.
Knowing that does not change perception, it helps us rationalize the bad news. We need something to happen we do not expect that is good. I want to hear they win in arbitration and are awarded $1 billion plus. I want to hear the global de-stocking that happened in Q3 is over and orders and pricing are firming at a faster than expected pace. I want to hear that Kuwait has come back to the table or Sabic (Saudi Basic Industries) want the commodity business and the proceeds are far more than currently projected. I want to hear that because of any of these the dividend is going to be partially restored. We see the projection for debt reduction, come back to us in 6 months and tell us you are ahead of pace paying off the bridge loan.
Any of these will tell investors that the rationalizing the bad news was not insane but logical and that the events that happened could not be avoided. More bad news tells us that perhaps management is not taking into account various alternative scenarios when planning or if they are, not putting enough stock in them possibly happening and not preparing appropriately for them.
I see one of two books being written about Dow CEO Andrew Liveris down the road. One is about how the global slowdown forced a poorly planned merger on the company and eventually cost him his career. The other is a book about how he deftly managed the company through the worse economic conditions in over 80 years, completed the merger and created the world’s preeminent specialty chemical company accomplishing the vison he had when he took it over. Either one could be written now. We are at the proverbial fork in the road.
Personally, I am rooting for the second one…
Disclosure (“none” means no position):Long DOW
Visit the ValuePlays Bookstore for Great Investing Books
One reply on “Dow Chemical / Rohm & Haas Settle”
Todd,
As far as Dow is concerned it is you that has the credibility problem, you have been pumping Dow and pumping Dow for over 18 months now and bought into all of Liveris’s BS without questioning any of it in the slightest – read through the cringe inducing interview that you did with him last year and you will know what i mean.
Look at everything Liveris has said and done – went on and on about earning $3 per share in the next trough despite having a clearly highly cyclical company.. well they didnt earn that in 2008, wont in 2009 and no way will earn that when the real industry trough hits in 2010.
He went on and on about the Aramco JV and guys like you bought it and started ascribing value to it…Ras Tanura is a generation away from getting off the ground and is going to cost at least $15bn..even at aggressive D/E ratios, Dow is in absoloutely no position over the next 2-3 years to pony up its share of equity of even promise a backstop to the project finance.
He made a ridiculous deal for ROH well into the credit crunch and had the gall to issue quotes like “a one day premium is a fascination question”. He then went public with his “not on my watch” assertion about the dividend and promptly cut in. Now Liveris pretends that the deal is some sort of victory for Dow shareholders – while paying 15% in coupons on the preferred.
Also Dow’s CFO tried to take the investment community for a ride on the call by stating that there was no dilution from the preferred – of course there is dilution..there is earnings dilution of over 35% – who cares about the sharecount alone..all im interested in is the EPS attributable to me as a common shareholder.
Now Dow is spinning the whole “other party interest” in the PE assets story and ppl like you seem to buy the fact that SABIC is interested in Dow’s assets – pls THINK before you write stuff like that.. SABIC has the most competitive assets and does not need Dow’s rubbish – it also does not need a distribution platform like the Kuwaitis did having bought GE Plastics a couple of years ago.
Please think through your investments – hope is not an investment strategy.